Literature DB >> 25504248

Cell accumulation and antileishmanial effect of exogenous and endogenous protoporphyrin IX after photodynamic treatment.

Jairo E Mateus1, Wilfredo Valdivieso1, Indira P Hernández1, Fernando Martínez2, Edgar Páez2, Patricia Escobar1.   

Abstract

INTRODUCTION: Photodynamic therapy (PDT) using 5-aminolevulinic acid-induced protoporphyrin IX (ALA-PpIX) constitutes an interesting alternative for cutaneous leishmaniasis treatment.
OBJECTIVE: To evaluate the production of PpIXbased on the administration of ALA and MAL and the effect of ALA-PDTat cellular level on non-infected and infected THP-1 cells using Leishmania ( Viannia ) panamensis or Leishmania ( Leishmania ) infantum (syn Leishmania chagasi ) parasites.
MATERIALS AND METHODS: Protoporphyrin IX (PpIX) production and mitochondrial colocalization were evaluated by confocal microscopy. Cell toxicities were evaluated after treatment with the compounds, followed by light irradiation (597-752 nm) at 2.5 J/cm 2 fluency using a colorimetric MTT assay for THP-1 cells and a standard microscopic analysis of parasites. RESULTS were expressed as compound concentration activity against 50% of cells or parasites (CC 50 or IC 50 ).
RESULTS: ALA or MAL induced an endogenous PpIX with a red fluorescence localized mainly in the mitochondria inside human cells. ALA and MAL-PDT induced a similar range of toxicities on THP-1 cells (CC 50 0.16 ± 0.01 mM and 0.33 ± 0.019 mM, respectively) without any apparent inhibition of intracellular parasites in the infected cells as compared to untreated controls. Exogenous PpIX-PDT was toxic to THP-1 cells (CC 50 0.00032 ± 0.00002 mM), L. (L.) infantum (IC 50 0.003 ± 0.0001 mM) and L. (V.) panamensis (IC 50 0.024 ± 0.0001 mM) promastigotes.
CONCLUSIONS: Despite the effectiveness of exogenous PpIX on promastigotes and the production of PpIX by human infected cells, treatment with ALA or MAL before irradiation was unable to completely destroy L. (L.) infantum or L. (V.) panamensis intracellular amastigotes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25504248     DOI: 10.1590/S0120-41572014000400012

Source DB:  PubMed          Journal:  Biomedica        ISSN: 0120-4157            Impact factor:   0.935


  4 in total

1.  Development of a novel formulation with hypericin to treat cutaneous leishmaniasis based on photodynamic therapy in in vitro and in vivo studies.

Authors:  Andrés Montoya; Alejandro Daza; Diana Muñoz; Karina Ríos; Viviana Taylor; David Cedeño; Iván D Vélez; Fernando Echeverri; Sara M Robledo
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

2.  [Successful treatment of Old World cutaneous leishmaniasis with red or green light photodynamic therapy].

Authors:  Sven-Niklas Burmann; Frank Oellig; Alexandros Paschos; Silke C Hofmann; Percy Lehmann; Alexander Kreuter; Galina Balakirski
Journal:  Dermatologie (Heidelb)       Date:  2022-08-11

Review 3.  Chlorin, Phthalocyanine, and Porphyrin Types Derivatives in Phototreatment of Cutaneous Manifestations: A Review.

Authors:  Sarah Raquel De Annunzio; Natalia Caroline Silva Costa; Rafaela Dalbello Mezzina; Márcia A S Graminha; Carla Raquel Fontana
Journal:  Int J Mol Sci       Date:  2019-08-08       Impact factor: 5.923

4.  Nanoemulsions with Chloroaluminium Phthalocyanine and Paromomycin for Combined Photodynamic and Antibiotic Therapy for Cutaneous Leishmaniasis.

Authors:  Sandra Milena Leal Pinto; Luis Alexandre Muehlmann; Lucía Liliana Mantilla Ojeda; Angélica María Vera Arias; Martha Viviana Roa Cordero; María de Fátima Menezes Almeida Santos; Ricardo Bentes Azevedo; Patricia Escobar Rivero
Journal:  Infect Chemother       Date:  2021-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.